Lias-Booker Ava
Known title: DirectorCIK: 0001914273
Lias-Booker Ava's purchase track record
Lias-Booker Ava has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/29/2025 | DOC | $89K | -0.5% | +5.1% | +23.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| DOC | ▲ Buy | Grant | 9,744 | $0 | 5/6/2026 | View on chart |
| DOC | ▲ Buy | Open Market | 5,000 | $89K | 4/29/2025 | View on chart |
| DOC | ▲ Buy | Grant | 10,657 | $0 | 4/25/2025 | View on chart |
| DOC | ▲ Buy | Grant | 9,575 | $0 | 4/26/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Healthpeak Sets Q3 2026 Earnings Date and Declares Q4 Dividend
Healthpeak Properties announced the dates for its third‑quarter 2026 earnings release, conference call, and webcast. The company also declared a monthly common‑stock cash dividend for the fourth quarter of 2026. These updates give investors a schedule for upcoming earnings and confirm the firm’s continued dividend payments, which can influence trading activity.
Healthpeak Sets Q3 2026 Earnings Date and Declares Q4 Dividend. Healthpeak Properties announced the dates for its third‑quarter 2026 earnings release, conference call, and webcast. The company also declared a monthly common‑stock cash dividend for the fourth quarter of 2026. These updates give investors a schedule for upcoming earnings and confirm the firm’s continued dividend payments, which can influence trading activity.